Aromatase and other steroidogenic genes in endometriosis: translational aspects.
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Endometriosis is a common, chronic and estrogen-dependent gynaecological disorder associated with pelvic pain and infertility. In addition to, or perhaps as a consequence of, immune, environmental and genetic factors, endometriotic lesions show high estradiol (E2) biosynthesis and low E2 inactivation compared with normal endometrium. Current medical therapies of pain, which aim to lower circulating E2 concentrations, are not effective in at least half of these patients. We and others recently demonstrated the expression of a few steroidogenic genes in endometriosis. The most important genes in this group are steroidogenic acute regulatory protein (StAR) and aromatase. Both are essential for E2 production. Prostaglandin E2 (PGE2) is the most potent known stimulator of both StAR and aromatase. PGE2 production in endometriosis is up-regulated by increased levels of the enzyme cyclo-oxygenase-2 (COX-2) in this tissue. COX-2 in turn is stimulated by E2, interleukin-1β (IL-1β) and PGE2 itself in endometrial and endometriotic cells. Thus, there is a positive feedback loop that favours continuous formation of E2 and PGE2 in endometriosis. These basic findings led to recent phase-II studies employing aromatase inhibitors in the treatment of endometriosis. Aromatase inhibitors treat both postmenopausal and premenopausal endometriosis at least as effectively as the existing medical treatments. In premenopausal women, we and others administered aromatase inhibitors in combination with an ovarian-suppressant treatment. In this review, we emphasize the most recent basic studies in detail and provide a short summary of recent clinical trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there are a number of reports that aromatase is expressed in endometriosis lesions with evidence of a positive feed-forward loop involving local biosynthesis of both E2 and the pro-inflammatory regulator prostaglandin E2 [69,98].”
From Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders (2018) · cites this paper as [69]
In the citing paper
“there are a number of reports that aromatase is expressed in endometriosis lesions with evidence of a positive feed-forward loop involving local biosynthesis of both E2 and the pro-inflammatory regulator prostaglandin E2 [69,98].”
From Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders (2018) · cites this paper as [69]
In the citing paper
“PGE 2 is the most potent known stimulator of P450arom in endometriotic stromal cells (10,13,15).”
From Prostaglandin E2 Via Steroidogenic Factor-1 Coordinately Regulates Transcription of Steroidogenic Genes Necessary for Estrogen Synthesis in Endometriosis (2009) · cites this paper as [15]
In the citing paper
“The similarity of the molecular biology of TIAR in various tissues with that described in endometriosis [39–41, 59–62] strongly suggests that this represents the common underlying mechanisms of both processes”
From The pathophysiology of endometriosis and adenomyosis, tissue injury and repair (2009) · cites this paper as [61]
In the citing paper
“The recent evidence that women, despite the hypogonatrophic effect obtained from combined oral contraceptives (COCs), have increased hormone levels in endometriosis implants compared to controls ( 61 )”
From Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism (2022) · cites this paper as [61]
Citations
Cites
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Aromatase Cytochrome P450, The Enzyme Responsible for Estrogen Biosynthesis*
SIMPSON, E. R., MAHENDROO, M. S., MEANS, G. D., KILGORE, M. W., HINSHELWOOD, M. M., GRAHAM-LORENCE, S., AMARNEH, B., ITO, Y., FISHER, C. R., MICHAEL, M. D., et al. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-342 · Cited by 1,537
Self-citationSource of Estrogen Production in Postmenopausal Women1
GRODIN, J. M., SIITERI, P. K., & MACDONALD, P. C. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-36-2-207 · Cited by 959
Frasor, J., Danes, J. M., Komm, B., Chang, K. C. N., Lyttle, C. R., & Katzenellenbogen, B. S. (2003) · Endocrinology · doi:10.1210/en.2003-0567 · Cited by 876
Simpson, E. R., Clyne, C., Rubin, G., Boon, W. C., Robertson, K., Britt, K., Speed, C., & Jones, M. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081601.142703 · Cited by 773
Kao, L. C., Germeyer, A., Tulac, S., Lobo, S., Yang, J. P., Taylor, R. N., Osteen, K., Lessey, B. A., & Giudice, L. C. (2003) · Endocrinology · doi:10.1210/en.2003-0043 · Cited by 696 · cited 2×
“…endometriosis exhibits multiple molecular abnormalities that may be linked to aberrant production of estrogen, PGs, cytokines and decreased production of molecules important for decidual transformation of stromal cells (Lessey et al., 1994; Tseng et al., 1996; Kao et al., 2003; Wu et al., 2005).”
BackgroundResultAromatase expression in endometriosis.
Noble, L. S., Simpson, E. R., Johns, A., & Bulun, S. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550748 · Cited by 566 · cited 5×
“…and expression of protein and mRNA in the stromal cell component of endometriosis, whereas StAR or aromatase expression was either absent or barely detectable in the eutopic endometrium of disease-free women (Noble et al., 1996, 1997; Tsai et al., 2001; Gurates et al., 2002; Sun et al., 2003).”
BackgroundInfluentialSelf-citationStocco, D. M., Wang, X., Jo, Y., & Manna, P. R. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0532 · Cited by 538
Aberrant integrin expression in the endometrium of women with endometriosis
Lessey, B. A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.2.643 · Cited by 514
Zhao, Y. D., Agarwal, V. R., Mendelson, C. R., & Simpson, E. R. (1996) · Endocrinology · doi:10.1210/en.137.12.5739 · Cited by 434
Harada, N., Utsumi, T., & Takagi, Y. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11312 · Cited by 361
Murakami, M., Nakashima, K., Kamei, D., Masuda, S., Ishikawa, Y., Ishii, T., Ohmiya, Y., Watanabe, K., & Kudo, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305108200 · Cited by 344
Origin of Estrogen in Normal Men and in Women with Testicular Feminization*
MACDONALD, P. C., MADDEN, J. D., BRENNER, P. F., WILSON, J. D., & SIITERI, P. K. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-49-6-905 · Cited by 321
Kitawaki, J., Noguchi, T., Amatsu, T., Maeda, K., Tsukamoto, K., Yamamoto, T., Fushiki, S., Osawa, Y., & Honjo, H. (1997) · Biology of Reproduction · doi:10.1095/biolreprod57.3.514 · Cited by 305
Mahendroo, M. S., Mendelson, C. R., & Simpson, E. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36538-x · Cited by 304 · cited 3×
“In addition to promoter II-specific sequences, transcripts containing two other unique sequences, untranslated exons I.3 and I.4, are present in adipose tissue and in adipose-tissue fibroblasts maintained in culture (Mahendroo et al., 1993).”
BackgroundDistribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis
Ota, H., Igarashi, S., Sasaki, M., & Tanaka, T. (2001) · Human Reproduction · doi:10.1093/humrep/16.3.561 · Cited by 302
Prostaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells
Noble, L. S. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.600 · Cited by 301
Self-citationTseng, J. F. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.3.1118 · Cited by 292
Bruner, K. L., Matrisian, L. M., Rodgers, W. H., Gorstein, F., & Osteen, K. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119478 · Cited by 287
Treatment of severe postmenopausal endometriosis with an aromatase inhibitor
Takayama, K., Zeitoun, K., Gunby, R. T., Sasano, H., Carr, B. R., & Bulun, S. E. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00022-3 · Cited by 270
Self-citationAromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target
Zeitoun, K. M., & Bulun, S. E. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00393-3 · Cited by 256 · cited 2×
“Use of receptor-selective agonists, however, showed that EP 2 receptor is primarily responsible for PGE 2 -mediated aromatase expression in endometriotic stromal cells (Zeitoun and Bulun, 1999).”
BackgroundSelf-citationIsolation, characterization, and comparison of human endometrial and endometriosis cells in vitro
Ryan, I. P. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.3.642 · Cited by 248
Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens
Brueggemeier, R. W., Quinn, A. L., Parrett, M. L., Joarder, F. S., Harris, R. E., & Robertson, F. M. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00050-6 · Cited by 238
Ailawadi, R. K., Jobanputra, S., Kataria, M., Gurates, B., & Bulun, S. E. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.09.029 · Cited by 236
Self-citationManna, P. R., Dyson, M. T., Eubank, D. W., Clark, B. J., Lalli, E., Sassone-Corsi, P., Zeleznik, A. J., & Stocco, D. M. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.1.0759 · Cited by 232
Progestins for symptomatic endometriosis: a critical analysis of the evidence
Vercellini, P., Cortesi, I., & Crosignani, P. G. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)00193-3 · Cited by 232
Zhao, Y., Nichols, J. E., Bulun, S. E., Mendelson, C. R., & Simpson, E. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.16449 · Cited by 227
Self-citationSoysal, S. (2004) · Human Reproduction · doi:10.1093/humrep/deh035 · Cited by 227 · cited 8×
“Thus, an aromatase inhibitor was administered together with a GnRH agonist, a progestin, progesterone or a combination oral contraceptive in four phase-II trials (Amsterdam et al., 2003; Ailawadi et al., 2004; Shippen and West, 2004; Soysal et al., 2004).”
BackgroundMethodInfluentialZeitoun, K., Takayama, K., Michael, M. D., & Bulun, S. E. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.2.0229 · Cited by 216 · cited 8×
“Production and action of PGE2 in endometriosis PGE2 plays a key role in the estrogen biosynthetic pathway in endometriotic tissue, because it is a potent stimulator of the key steroidogenic genes (Noble et al., 1997; Zeitoun et al., 1999; Tsai et al., 2001; Sun et al., 2003).”
BackgroundInfluentialSelf-citationSebastian, S., & Bulun, S. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.10.4600 · Cited by 198
Self-citationBulun, S. E. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.2.428 · Cited by 188
Self-citationRole of aromatase in endometrial disease
Bulun, S. E., Yang, S., Fang, Z., Gürateş, B., Tamura, M., Zhou, J., & Sebastian, S. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00134-0 · Cited by 159
Self-citationEstrogen Excess Associated with Novel Gain-of-Function Mutations Affecting the Aromatase Gene
Shozu, M., Sebastian, S., Takayama, K., Hsu, W.-T., Schultz, R. A., Neely, K., Bryant, M., & Bulun, S. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021559 · Cited by 158
Self-citationTsai, S.-J., Wu, M.-H., Lin, C.-C., Sun, H. S., & Chen, H.-M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8082 · Cited by 155
Structural characterization of the human estrogen synthetase (aromatase) gene
Harada, N., Yamada, K., Saito, K., Kibe, N., Dohmae, S., & Takagi, Y. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91954-q · Cited by 148
Steroidogenic Acute Regulatory Protein
Christenson, L. K., & Strauss, J. F. (2001) · Archives of Medical Research · doi:10.1016/s0188-4409(01)00338-1 · Cited by 146
Jabbour, H. N., Milne, S. A., Williams, A. R. W., Anderson, R. A., & Boddy, S. C. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2033 · Cited by 135
Distinct Regulation of Cyclooxygenase-2 by Interleukin-1β in Normal and Endometriotic Stromal Cells
Wu, M.-H., Wang, C.-A., Lin, C.-C., Chen, L.-C., Chang, W.-C., & Tsai, S.-J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1612 · Cited by 127
Manna, P., Eubank, D., Lalli, E., Sassone-Corsi, P., & Stocco, D. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0300381 · Cited by 122
Tamura, M., Sebastian, S., Yang, S., Gurates, B., Fang, Z., & Bulun, S. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8594 · Cited by 117
Self-citationSun, H. S., Hsiao, K.-Y., Hsu, C.-C., Wu, M.-H., & Tsai, S.-J. (2003) · Endocrinology · doi:10.1210/en.2003-0289 · Cited by 114 · cited 12×
“Production and action of PGE2 in endometriosis PGE2 plays a key role in the estrogen biosynthetic pathway in endometriotic tissue, because it is a potent stimulator of the key steroidogenic genes (Noble et al., 1997; Zeitoun et al., 1999; Tsai et al., 2001; Sun et al., 2003).”
BackgroundInfluentialTamura, M., Deb, S., Sebastian, S., Okamura, K., & Bulun, S. E. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.09.076 · Cited by 107 · cited 2×
“Additionally, vascular endothelial growth factor (VEGF) and E2 rapidly induced COX-2 in uterine endothelial cells ( Tamura et al., 2003, 2004; Wu et al., 2005).”
BackgroundSelf-citationEndometriosis and Infertility: New Concepts
Ryan, I. P., & Taylor, R. N. (1997) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199706000-00021 · Cited by 106
Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells
Richards, J. A., Petrel, T. A., & Brueggemeier, R. W. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00187-x · Cited by 92
Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue
Fang, Z., Yang, S., Gurates, B., Tamura, M., Simpson, E., Evans, D., & Bulun, S. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8683 · Cited by 91 · cited 1×
“We and others demonstrated abundant aromatase expression and local estrogen production in endometriotic tissue (Kitawaki et al., 1997; Zeitoun et al., 1999; Bulun et al., 2001; Fang et al., 2002; Gurates et al., 2002; Yang et al., 2002).”
BackgroundSelf-citationAromatase Deficiency and Estrogen Resistance: From Molecular Genetics to Clinic
Bulun, S. E. (2000) · Seminars in Reproductive Medicine · doi:10.1055/s-2000-13481 · Cited by 90
Self-citationNi, H., Sun, T., Ding, N.-Z., Ma, X.-H., & Yang, Z.-M. (2002) · Biology of Reproduction · doi:10.1095/biolreprod67.1.351 · Cited by 90
Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor
Shippen, E., & West, W. J. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.11.027 · Cited by 87
Sebastian, S., Takayama, K., Shozu, M., & Bulun, S. E. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0123 · Cited by 85
Self-citationInterleukin-1 Family Expression in Human Breast Cancer: Interleukin-1 Receptor Antagonist
MILLER, L. J., Kurtzman, S. H., Anderson, K. L., Wang, Y., Stankus, M., Renna, M., Lindquist, R. R., Barrows, G. H., & Kreutzer, D. L. (2000) · Cancer Investigation · doi:10.3109/07357900009012171 · Cited by 85
Tamura, M., Sebastian, S., Gurates, B., Yang, S., Fang, Z., & Bulun, S. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8796 · Cited by 82
Self-citationYang, S., Fang, Z., Suzuki, T., Sasano, H., Zhou, J., Gurates, B., Tamura, M., Ferrer, K., & Bulun, S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8486 · Cited by 77
Self-citationWT1 and DAX-1 regulate SF-1-mediated human P450arom gene expression in gonadal cells
Gürateş, B., Amsterdam, A., Tamura, M., Yang, S., Zhou, J., Fang, Z., Amin, S., Sebastian, S., & Bulun, S. E. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(03)00198-9 · Cited by 74
Self-citationRazzi, S., Fava, A., Sartini, A., De Simone, S., Cobellis, L., & Petraglia, F. (2004) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1046/j.1471-0528.2003.00038.x · Cited by 70
Gurates, B., Sebastian, S., Yang, S., Zhou, J., Tamura, M., Fang, Z., Suzuki, T., Sasano, H., & Bulun, S. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020522 · Cited by 70
Self-citationTamura, M., Sebastian, S., Yang, S., Gurates, B., Ferrer, K., Sasano, H., Okamura, K., & Bulun, S. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201347200 · Cited by 63
Self-citationSun, T., Li, S.-J., Diao, H.-L., Teng, C.-B., Wang, H.-B., & Yang, Z.-M. (2004) · Reproduction · doi:10.1530/rep.1.00121 · Cited by 34
Karuppu, D., Kalus, A., Simpson, E. R., & Clyne, C. D. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1020531329686 · Cited by 32
Junior, M. F. T., Sebastian, S., Yang, S., Gürateş, B., Fang, Z., Okamura, K., & Bulun, S. E. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0310095 · Cited by 22
Self-citationEstrogen Excess Associated With Novel Gain-of-Function Mutations Affecting the Aromatase Gene
Shozu, M., Sebastian, S., Takayama, K., Hsu, W.-T., Schultz, R. A., Neely, K., Bryant, M., & Bulun, S. E. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000109265.21876.17 · Cited by 10
Self-citation
Research works printed but not linked: 11
- Bulun, 1994, J Clin Endocrinol Metab, 78, 428
- Lessey, 1994, J Clin Endocrinol Metab, 79, 643
- Noble, 1996, J Clin Endocrinol Metab, 81, 174
- Noble, 1997, J Clin Endocrinol Metab, 82, 600
- Ryan, 1994, J Clin Endocrinol Metab, 78, 642
- Sebastian, 2001, J Clin Endocrinol Metab, 86, 4600, 10.1210/jcem.86.10.7947 · doi:10.1210/jcem.86.10.7947 · Paper page
- Simpson, 1994, Endocr Rev, 15, 342
- Tamura, 2002, J Clin Endocrinol Metab, 87, 3263
- Tseng, 1996, J Clin Endocrinol Metab, 81, 1118
- Yang, 2002, J Clin Endocrinol Metab, 87, 2336
- Zhao, 1996, Endocrinology, 137, 5739, 10.1210/endo.137.12.8940410 · doi:10.1210/endo.137.12.8940410 · Paper page
Cited by
Endometriosis is a chronic systemic disease: Clinical challenges and novel innovations
Taylor, H. S., Kotlyar, A. M., & Flores, V. A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00389-5 · Cited by 1,425
The pathophysiology of endometriosis and adenomyosis, tissue injury and repair
Leyendecker, G., Wildt, L., & Mall, G. (2009) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-009-1191-0 · Cited by 418
“endometriosis [39–41, 59–62] strongly suggests that this represents the common underlying mechanisms of both processes (Fig.”
BackgroundPathogenic mechanisms in endometriosis-associated infertility
Gupta, S., Goldberg, J. M., Aziz, N., Goldberg, E., Krajcir, N., & Agarwal, A. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.02.093 · Cited by 409
Pathophysiology and Immune Dysfunction in Endometriosis
Ahn, S. H., Monsanto, S. P., Miller, C., Singh, S. S., Thomas, R., & Tayade, C. (2015) · BioMed Research International · doi:10.1155/2015/795976 · Cited by 397
Contemporary genetic technologies and female reproduction
The Evian Annual Reproduction (EVAR) Workshop Group 2010, Fauser, B. C. J. M., Diedrich, K., Bouchard, P., Dominguez, F., Matzuk, M., Franks, S., Hamamah, S., Simon, C., Devroey, P., et al. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr033 · Cited by 349
Metadata
- Authors
- Attar, E., & Bulun, S. E.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Attar, E.
- ORCID
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-08-25
- Volume
- 12
- Issue
- 1
- Pages
- 49-56
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2143048167
- Semantic Scholar
- 3b4b43f8e922c94c2584dcd15b01db33ae2eb42c
- Cited by
- 255
- References
- 60
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 9 · 2023: 9 · 2022: 11 · 2021: 15 · 2020: 9 · 2019: 12 · 2018: 4 · 2017: 9 · 2016: 8 · 2015: 17 · 2014: 15 · 2013: 11 · 2012: 17
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction Update (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 36891)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Keywords
- endometriosis, aromatase, steroidogenic genes, steroidogenic acute regulatory protein, estradiol synthesis, prostaglandin E2, cyclooxygenase-2, IL-1β, aromatase inhibitors, ovarian suppression, estrogen-dependent disease, infertility, pelvic pain
- MeSH terms
- Steroidogenic Acute Regulatory Protein, Aromatase, Cells, Cultured, Endometriosis, Estrogens, Female, Humans, Inflammation, Phosphoproteins, Steroids, Protein Biosynthesis, Dinoprostone, Signal Transduction, Gene Expression Regulation, Enzymologic, Stromal Cells, Aromatase Inhibitors, Cyclooxygenase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.